How Much Does Januvia Cost in 2026?
Januvia (sitagliptin) is a once-daily tablet for type 2 diabetes. Medicare negotiated $113 for a 30-day supply, 79% below the $527 list price, effective January 1, 2026. That is the deepest percentage cut of any of the ten first-cycle drugs. It is also, as of 2026, roughly what a generic sitagliptin costs in cash, which changes how you should read the headline.
- Medicare's negotiated price is $113 per 30-day supply, a 79% cut from the $527 list price and the largest reduction of the ten first-cycle drugs.
- Generic sitagliptin reached US pharmacies in 2026, with Sandoz in January and Teva and Apotex at the end of May.
- There is a second product, Zituvio, that is sitagliptin in a different chemical form. It is often cheaper, but your pharmacist cannot substitute it automatically. It needs its own prescription.
- Because the generic and the negotiated price are now in the same range, the cheapest route depends on your plan's tier, so it is worth asking rather than assuming.
What You Actually Pay
Figures are for a 30-day supply. List and negotiated prices are from CMS; what you pay depends on your coverage.
| Your situation | Typical cost |
|---|---|
| Medicare negotiated price, 2026 | $113 / 30 days |
| Medicare Part D, your share | up to $2,100 / year |
| Commercial insurance | copay or coinsurance |
| Uninsured, cash | ~$527 (list) |
The Zituvio Trap, and Why Your Pharmacist Cannot Just Swap It
Januvia is sitagliptin phosphate. Zituvio, approved in October 2023, is sitagliptin free base: the same active molecule in a different salt form, approved through its own application rather than as a generic of Januvia. That distinction has a real consequence. Zituvio is not AB-rated to Januvia, so a pharmacist cannot substitute it for your Januvia prescription the way they can substitute a true generic. It requires a new prescription written for Zituvio.
This matters because Zituvio has been advertised at cash prices well below both brand Januvia and, in some pharmacies, below generic sitagliptin phosphate. People read that, ask the pharmacy to switch, and are told no, and the reason is not obstruction. If you want to pursue it, the ask goes to your prescriber for a new prescription. Whether it is appropriate is their call, but the pricing difference is a legitimate reason to raise it.
What Medicare's Negotiated Price Does, and Does Not, Change
The headline number is not your copay.
$113 is the maximum fair price, the amount Medicare and your Part D plan pay for a 30-day supply of Januvia. What you are charged at the counter is still set by your plan's tier and cost-sharing rules.
It helps you directly if you pay coinsurance
Many plans charge a percentage of the drug's price on brand and specialty tiers. If you owe 25% of $527, that is far more than 25% of $113. When your share is a percentage, a lower negotiated price lowers your bill directly.
It may not change a flat copay
If your plan charges a fixed dollar copay for that tier, your copay can stay the same even though the plan is paying less. The benefit then shows up in the program's overall costs rather than your receipt.
It changes how fast you hit the cap
Your spending counts toward the $2,100 annual Part D out-of-pocket cap in 2026. A cheaper drug means a smaller share each month, which can mean you reach the cap later or not at all, so the year-end picture differs from past years.
It does not change coverage rules
A negotiated price does not force a plan to cover Januvia, drop prior authorization, or change its tier. Plans still set their own formularies, so check yours before you assume the new price applies to you.
Because tiers and cost-sharing vary so much between plans, the only way to know your real cost is to check Januvia against each plan's formulary. If you would rather have that done for you, our Find My Medicare Plan service checks your specific drugs against the plans available to you for a flat $99.
Is There a Generic for Januvia?
Yes. Generic sitagliptin phosphate reached US pharmacies in 2026, with Sandoz launching in January and Teva and Apotex at the end of May, and it is AB-rated so your pharmacist can substitute it. Separately, Zituvio is sitagliptin free base, a different salt form approved in October 2023, which is often cheaper but is not substitutable without a new prescription written for it.
Does Insurance Cover Januvia?
Usually, with conditions
Januvia is covered by Medicare Part D and most commercial plans, usually on a brand tier, commonly with prior authorization or step therapy requiring metformin first. Now that generic sitagliptin exists, expect plans to prefer the generic and to move the brand to a worse tier at renewal, which is a normal formulary change rather than a denial.
If you are denied or moved a tier
A denial is not the end, and a tier change at renewal is not either. Your prescriber can submit a letter of medical necessity or a formulary exception, and you have formal appeal rights. See how to appeal an insurance denial and what to do when a plan drops your drug.
How to Pay Less
Ask for generic sitagliptin, then ask what it actually costs
The generic is AB-rated and substitutable. Compare its copay under your plan against its cash price, and against the $113 negotiated price if you are on Part D, because on a drug this recently genericized the three numbers can be surprisingly close.
Ask your prescriber about Zituvio if cash price is what matters
Zituvio is sitagliptin in a different salt form and is often advertised well below the alternatives, but it needs its own prescription because it is not substitutable. If you are paying cash, it is worth asking about.
On Medicare, check Extra Help and the payment plan
Extra Help (the Low Income Subsidy) sharply reduces Part D costs and its income limits are higher than most people expect. The Medicare Prescription Payment Plan can also spread your Part D costs evenly across the year instead of front-loading them, and you opt in through your plan.
Check the tier before you commit to a plan
The same drug can cost very different amounts across plans in the same ZIP code. During open enrollment, compare Januvia on each plan's formulary, and remember the plan that was cheapest last year may not be this year.
Push back on a bill you have already received
If you were billed more than you expected, or a claim was processed wrong, CareRoute Bill Defense reviews and disputes medical bills, with no fee unless we save you money.
Not sure which plan covers Januvia best?
For a flat $99, we research the Medicare plans available to you and check them against your specific drugs and doctors, then hand you a clear comparison. We are independent, sell no insurance, and take no commissions.
Frequently Asked Questions
Is there a generic for Januvia?
Yes. Generic sitagliptin phosphate became available in US pharmacies in 2026, with Sandoz launching in January and Teva and Apotex at the end of May. It is AB-rated to Januvia, so your pharmacist can substitute it without a new prescription. There is also Zituvio, which is sitagliptin free base, a different salt form approved in its own right in October 2023. Zituvio is often cheaper but is not AB-rated, so it cannot be substituted automatically and requires a prescription written specifically for it.
Why can't my pharmacist give me Zituvio instead of Januvia?
Because Zituvio is not a generic of Januvia. Januvia is sitagliptin phosphate; Zituvio is sitagliptin free base, the same active molecule in a different chemical form, approved through its own FDA application rather than as a substitutable generic. Pharmacists can only swap products that are AB-rated to what was prescribed. Zituvio is not, so it needs a new prescription written for it. If its cash price is attractive to you, raise it with your prescriber rather than at the counter.
What is Medicare's negotiated price for Januvia?
Medicare negotiated a maximum fair price of $113 for a 30-day supply of Januvia, effective January 1, 2026. That is 79% below the $527 list price CMS used as the comparison. Januvia was one of the first ten drugs in the Medicare Drug Price Negotiation Program, selected because it was among the highest-spending Part D drugs without generic or biosimilar competition at the time. The price applies automatically at the pharmacy for Part D members.
Will the negotiated price lower what I actually pay for Januvia?
It can, but it is not your new copay. The maximum fair price is what Medicare and your Part D plan pay the pharmacy, not automatically what you are charged. If your plan charges coinsurance, a percentage of the drug price, a lower negotiated price lowers your share directly. If your plan charges a flat copay for that tier, your copay may not change at all. Either way, your total Part D out-of-pocket is capped at $2,100 in 2026, after which covered drugs cost you nothing for the rest of the year.
Does insurance cover Januvia?
Generally yes. Januvia is covered by Medicare Part D and most commercial plans, though plans commonly require prior authorization and sometimes step therapy, meaning you try a cheaper option first. The tier it sits on, not whether it is covered, is usually what decides your cost, and the same drug can sit on different tiers in two plans sold in the same ZIP code. Check your plan's formulary for the tier and any restrictions before you fill it.
Related
Sources
- CMS, Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026 (maximum fair price and list-price comparison)
- CMS / Medicare.gov (Part D out-of-pocket cap, $2,100 in 2026, and the $615 maximum deductible)
- FDA Orange Book and Purple Book (approval and substitutability status for sitagliptin)
- Merck published list price and patient-support program terms
Prices are national figures for a 30-day supply at a common dose and vary by pharmacy, dose, and plan. List prices are the figures CMS published as its negotiation comparison. This page is educational and is not medical or financial advice: do not start, stop, or switch a prescription on the basis of price without talking to your prescriber. Last updated November 20, 2026.